Early research (Phase 1)Study completedNCT02266706
What this trial is testing
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Who this might be right for
Proven or Suspected Gram-negative Bacterial InfectionPeri-operative Prophylaxis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 43